In contrast, TMX2 was detrimental roles in different human cancers, including BLCA (p = 0.0093, Figure 2E), BRCA (p = 0.026, Figure 2F), HNSC (p = 0.012, Figure 2G), LIHC (p = 0.0026, Figure 2I), LUAD (p = 0.0028, Figure 2J), and UVM (p = 0.0021, Figure 2K). Here, TMX2 is linked to cancer.